Opinion: Biodefense Innovation Needed

To protect against biological threats, federal agencies and other key stakeholders should commit to a strategic, unified approach.

Written byJoe Lieberman and Tom Ridge
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, NIAIDFrom the early days of space exploration, NASA assumed that astronauts could encounter extraterrestrial microorganisms during their missions. Would these organisms be entirely alien? Could they be detected? If they caused disease, could astronauts learn enough about them to determine treatments?

Over time, NASA innovations led to the development of detectors now used on the International Space Station (ISS) to locate and eradicate colonies of organisms before they interfere with astronaut health or ISS functioning (a remarkable lab-on-a-chip). Others approached the challenge from the perspective of life functions. For example, instead of trying to identify an entire organism, a detector could find evidence of biomarkers, metabolism, or even sound.

Exposure to novel microbes is not just an extraterrestrial concern. Pathogens seriously impact human health each day. Biodefense is the field of activity in which we work to predict, prevent, and respond to major infectious disease threats, whether they come from nature, terrorists, or lab accidents. Civilian and military planners determine which biological threats are most likely, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies